Makers Labs - Makers Laboratories Share Price

152.854.90 (3.31%)

BSE

Closed
As On:
As On: 19 Jun, 2026, 03:40 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-152.85
Previous Day	-147.95

Makers Labs Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Makers Labs Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	36.51	35.99	34.53	35.27	34.02
Total Income Growth (%)	1.44	4.24	-2.09	3.65	19.12
Total Expenses	31.61	32.65	33.02	33.11	31.74
Total Expenses Growth (%)	-3.17	-1.13	-0.28	4.32	14.62
EBIT	4.90	3.35	1.51	2.16	2.29
EBIT Growth (%)	46.44	121.36	-29.88	-5.63	161.85
Profit after Tax (PAT)	1.09	0.94	-0.12	0.44	-0.05
PAT Growth (%)	16.63	-	-126.68	-	-
EBIT Margin (%)	13.43	9.30	4.38	6.12	6.72
Net Profit Margin (%)	2.99	2.60	-0.34	1.24	-0.13
Basic EPS (₹)	1.85	1.59	-0.20	0.74	0.08

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	11.30	12.71	13.17	13.77	9.73
Total Income Growth (%)	-11.08	-3.50	-4.34	41.54	-2.96
Total Expenses	12.34	12.70	13.42	13.96	11.60
Total Expenses Growth (%)	-2.83	-5.40	-3.87	20.32	8.06
EBIT	-1.04	0.01	-0.25	-0.20	-1.88
EBIT Growth (%)	0.00	-	-	-	-
Profit after Tax (PAT)	-0.96	-0.17	-0.31	-0.27	-1.40
PAT Growth (%)	-	-	-	-	-
EBIT Margin (%)	-9.19	0.08	-1.94	-1.43	-19.32
Net Profit Margin (%)	-8.53	-1.36	-2.37	-1.98	-14.41
Basic EPS (₹)	-1.63	-0.29	-0.53	-0.46	-2.38

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	142.30	132.64	105.92	103.55	129.81
Total Revenue Growth (%)	7.29	25.23	2.28	-20.22	86.51
Total Expenses	131.16	118.44	109.83	104.39	114.13
Total Expenses Growth (%)	10.74	7.83	5.21	-8.53	70.61
Profit after Tax (PAT)	2.35	7.49	-6.26	-4.75	4.98
PAT Growth (%)	-68.61	-	-	-195.43	-
Operating Profit Margin (%)	8.47	12.82	-1.88	1.26	13.75
Net Profit Margin (%)	1.67	6.20	-6.00	-4.69	3.93
Basic EPS (₹)	3.99	12.70	-10.62	-7.90	10.12

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	50.94	53.87	50.24	43.68	53.26
Total Revenue Growth (%)	-5.44	7.22	15.01	-17.98	18.81
Total Expenses	52.95	48.94	57.20	50.46	52.94
Total Expenses Growth (%)	8.20	-14.44	13.35	-4.69	12.89
Profit after Tax (PAT)	-1.72	4.64	-6.95	-6.36	0.17
PAT Growth (%)	-137.06	-	-	-3,802.50	-
Operating Profit Margin (%)	-2.94	13.66	-10.84	-12.68	3.79
Net Profit Margin (%)	-3.41	10.80	-14.16	-14.95	0.32
Basic EPS (₹)	-2.91	7.87	-11.78	-10.58	0.35

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 11.09% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	166.62	147.95	161.26	152.30	144.33
Total Assets Growth (%)	12.62	-8.25	5.88	5.52	5.98
Total Liabilities	44.14	32.76	56.92	42.62	46.24
Total Liabilities Growth (%)	34.76	-42.45	33.55	-7.83	-6.81
Total Equity	122.48	115.19	104.34	109.67	98.09
Total Equity Growth (%)	6.32	10.40	-4.87	11.81	13.31
Current Ratio (x)	2.56	3.22	1.88	2.30	1.91
Total Debt to Equity (x)	0.07	0.05	0.28	0.17	0.29
Contingent Liabilities	0.00	6.62	9.56	8.81	8.10

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	73.54	71.40	86.15	84.79	85.48
Total Assets Growth (%)	3.00	-17.12	1.60	-0.81	8.04
Total Liabilities	19.10	15.32	34.70	26.51	35.18
Total Liabilities Growth (%)	24.67	-55.85	30.89	-24.64	19.29
Total Equity	54.43	56.08	51.45	58.28	50.30
Total Equity Growth (%)	-2.94	9.00	-11.72	15.86	1.37
Current Ratio (x)	1.13	1.19	0.81	0.92	0.72
Total Debt to Equity (x)	0.05	0.01	0.26	0.16	0.34
Contingent Liabilities	0.00	2.53	2.16	2.23	3.46

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	14.29	-4.08	0.84	-8.62	8.50
Net Cash used in Investing Activities	-14.69	19.75	-6.89	1.25	-11.79
Net Cash flow from Financing Activities	0.35	-15.84	5.74	5.78	0.33
Net Cash Flow	-0.05	-0.17	-0.31	-1.59	-2.96
Closing Cash & Cash Equivalent	0.20	0.24	0.41	0.72	2.31
Closing Cash & Cash Equivalent Growth (%)	-18.98	-41.33	-42.69	-68.71	-
Total Debt/ CFO (x)	0.33	-0.83	21.05	-1.33	2.02

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-2.02	-1.59	-3.06	-1.42	6.80
Net Cash used in Investing Activities	0.28	16.14	-2.04	-3.55	-8.78
Net Cash flow from Financing Activities	1.75	-14.56	5.12	4.94	1.77
Net Cash Flow	-9,000.00	-0.01	0.02	-0.04	-0.21
Closing Cash & Cash Equivalent	0.02	0.02	0.03	0.01	0.05
Closing Cash & Cash Equivalent Growth (%)	-5.00	-28.00	190.70	-81.70	-81.60
Total Debt/ CFO (x)	-1.34	-0.19	-4.44	-6.49	2.53

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	3.22	10.62	-9.93	-6.86	8.35
Return on Capital Employed (%)	8.98	12.21	-1.58	1.02	15.64
Return on Assets (%)	1.41	5.06	-3.88	-3.11	3.44
Interest Coverage Ratio (x)	21.33	15.78	1.32	2.60	12.37
Asset Turnover Ratio (x)	0.89	0.78	0.67	0.37	0.47
Price to Earnings (x)	34.01	10.16	-10.57	-12.14	18.05
Price to Book (x)	1.09	1.08	1.05	0.83	1.51
EV/EBITDA (x)	8.11	6.09	47.62	19.04	6.38
EBITDA Margin (%)	11.69	16.78	2.47	5.45	16.92

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-3.15	8.27	-13.51	-10.91	0.34
Return on Capital Employed (%)	-2.65	10.13	-8.81	-8.44	3.56
Return on Assets (%)	-2.33	6.50	-8.06	-7.50	0.20
Interest Coverage Ratio (x)	2.49	9.27	-1.60	-2.17	2.33
Asset Turnover Ratio (x)	0.69	0.55	0.57	0.50	0.64
Price to Earnings (x)	-46.51	16.42	-9.52	-9.07	526.32
Price to Book (x)	1.47	1.36	1.29	0.99	1.78
EV/EBITDA (x)	62.30	8.76	-30.54	-22.29	27.43
EBITDA Margin (%)	2.62	20.29	-5.31	-7.04	7.43

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Makers Labs	38.36	0.74	3.22	8.98	1.41	11.06	8.47	5.59	3.99	2.56	0.07	0.33
Pharmaids Pharm	-9.68	2.38	-24.58	-24.15	-13.42	0.00	-54.78	-41.50	-3.31	0.46	0.44	-5.15
Mercury Laboratories	21.12	1.76	8.32	11.24	6.11	0.36	9.97	6.36	40.28	3.85	0.13	1.75
Concord Drugs	72.99	1.59	2.17	5.92	1.40	14.62	4.04	1.33	0.95	2.53	0.28	-2.01
Bharat Immunological	-4.08	0.86	-19.42	-16.78	-9.18	-11.23	-35.44	-38.23	-3.95	0.36	0.80	6.45
Add More

Annual Ratios (%)

Choose from Peers

Source Natural
Sunil Healthcare
Fervent Syn
Phaarmasia Ltd
Samrat Pharma

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Makers Labs Stock Performance	3.31	-2.18	0.07	3.94	-2.92	39.27	-33.76
Pharmaids Pharm Stock Performance	-2.12	5.03	5.48	-8.16	-52.60	0.00	16.35
Mercury Laboratories Stock Performance	12.11	11.99	12.66	4.31	0.76	19.52	12.22
Concord Drugs Stock Performance	0.00	-3.03	-11.94	-8.82	141.76	169.89	115.99
Bharat Immunological Stock Performance	1.86	0.46	-0.91	-4.23	-32.00	-25.46	-71.20
Add More

Category	No. of Shares	Percentage
Promoters	36,15,356	61.27 %
Pledge	0	0.00 %
Others	22,85,020	38.73 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	61.27	61.27	61.27	61.27
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	38.73	38.73	38.73	38.73

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 05, 2026
Board Meeting
Quarterly Results
Jan 21, 2026
Board Meeting
Quarterly Results
Oct 16, 2025

Board Meetings

Announced on	Meeting on
May 05, 2026	May 26, 2026
Audited Results
Jan 21, 2026	Feb 10, 2026
Quarterly Results
Oct 16, 2025	Nov 07, 2025
Quarterly Results
Jul 25, 2025	Aug 08, 2025
Quarterly Results
May 13, 2025	May 26, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
May 22, 2019 Aug 01, 2019 10%
May 23, 2018 Jul 26, 2018 10%
Jun 29, 2017 Jul 20, 2017 10%
May 31, 2016 Aug 02, 2016 10%
May 29, 2015 Jul 28, 2015 10%
Bonus
No Data Available
Splits
No Data Available

Announced on	Ex-Date	Dividend%
May 22, 2019	Aug 01, 2019	10%
May 23, 2018	Jul 26, 2018	10%
Jun 29, 2017	Jul 20, 2017	10%
May 31, 2016	Aug 02, 2016	10%
May 29, 2015	Jul 28, 2015	10%

Rights

Announced on	Ex-Date
Nov 10, 2021	Mar 30, 2022
Rights ratio: 1 share for every 5 held at a price of Rs 150.0
Dec 09, 2000	Dec 20, 1999
Rights ratio: 1 share for every 1 held at a price of Rs 15.0
Jul 09, 1999	Dec 09, 1999
Rights ratio: 1 share for every 1 held at a price of Rs 15.0

AGM/EGM Meetings

Announced on	Meeting on
Jul 09, 2025	Aug 08, 2025
-
Jul 11, 2024	Aug 06, 2024
-
May 22, 2023	Aug 14, 2023
-
Jul 22, 2021	Aug 18, 2021
Book closure from Aug 13, 2021 to Aug 18, 2021
Aug 12, 2020	Sep 10, 2020
Book closure from Sep 5, 2020 to Sep 10, 2020

About Makers Labs

Makers Laboratories Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 90.19 Crore) operating in Pharmaceuticals sector.

Makers Laboratories Ltd. key Products/Revenue Segments include Formulations, Sale of services, Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 36.51 Crore, up 1.44 % from last quarter Total Income of Rs 35.99 Crore and up 7.32 % from last year same quarter Total Income of Rs 34.02 Crore. Company has reported net profit after tax of Rs 3.56 Crore in latest quarter.

The company’s top management includes Mr.R K P Verma, Mr.Nilesh Jain, Mr.Saahil Parikh, Mr.Prashant Godha, Ms.Dipti Shah, Mr.Vishal Jain, Mr.Piyush Ajmera. Company has Natvarlal Vepari & Co. as its auditors. As on 31-03-2026, the company has a total of .59 Crore shares outstanding.

Makers Labs Share Price Today is Rs. 152.85. On previous day, the Makers Labs Share Price (NSE) closed at Rs. 147.95, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 61.27% of the stake in Makers Labs shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Makers Labs stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Makers Labs shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Makers Labs stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Makers Labs Dividend: Ever since 1984, Makers Labs dividends has been paid out around 12 times. As on 19 Jun, 2026, 03:40 PM IST, The overall dividend yield for Makers Labs stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 3.99.

Makers Labs Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 36.51 Cr. of sales and 1.44% of quarterly net profit, there have been multiple ups and downs in the Makers Labs stock prices in the past few weeks. For example, Makers Labs stock price on 12th of June 2026 was around Rs. 156.85. Makers Labs share price now stands at an average of Rs. 152.85. Judging by last week's performance, stock is in down trend.

Makers Labs has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Makers Labs share.

Historical Prices and Performance:
Makers Labs, incorporated in 1984 is a Small Cap company (with a market cap of Rs. 90.19) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Makers Labs stock was 3.22%, 10.62%, -9.93%, -6.86% and 8.35% respectively.
The Makers Labs share gave a 3 year return of 39.02% as compared to Nifty 50 which gave a return of 28.03%.
Makers Labs announced 7.5% final dividend on null.

Key Metrics:
PE Ratio of Makers Labs is 37.13
Prices/Sales Ratio of Makers Labs is 0.57
Price/Book Ratio of Makers Labs is 0.71

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 37.13 and 0.71 respectively.

Leadership of Makers Labs :
Piyush Ajmera is Co. Secretary & Compl. Officer
R K P Verma is Chairman & Ind.Director
Saahil Parikh is Whole Time Director
Nilesh Jain is Whole Time Director
Vishal Jain is Independent Director
Dipti Shah is Independent Director
Prashant Godha is Non Independent Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

54 D, Kandivli Industrial Estate,Charkop, Kandivli (West),Mumbai, Maharashtra - 400067

Contact

investors@makerslabs.com

http://www.makerslabs.com

PE Ratio(x)	38.36
EPS - TTM(₹)	3.99
MCap(₹ Cr.)	90.19
MCap Rank	139
PB Ratio(x)	0.71
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	186.70
52W Low(₹)	109.00
MCap/Sales	0.57
Beta(1 Month)	2.50
BV/Share(₹)	207.57

1 Day	3.31%
1 Month	-1.77%
3 Months	-3.14%
1 Year	1.9%
3 Years	39.02%
5 Years	-25.38%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Makers Labs - Makers Laboratories Share Price

Key Metrics

Makers Labs share price insights

Makers Labs Share Price Returns

Makers Labs Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Makers Labs Top Searches

Corporate Actions

About Makers Labs

Executive Leadership

Auditors

FAQs about Makers Labs share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News